H. Rept. 116-319, Part 1: DHS Opioid Detection Resilience Act of 2019, Report to Accompany H.R. 4761, December 3, 2019 [open pdf - 377KB]
From the Purpose and Summary: "H.R. 4761, the 'DHS Opioid Detection Resilience Act of 2019' seeks to ensure U.S. Customs and Border Protection (CBP) officers, agents, and other personnel have adequate synthetic opioid detection equipment, and that the Department of Homeland Security (DHS) has a process to update synthetic opioid detection capability. H.R. 4761 addresses limitations in chemical screening devices used by CBP to detect fentanyl and other opioids. The bill would require CBP to implement a strategy to ensure that deployed chemical screening devices are able to identify synthetic opioids in an operational environment at a purity level of 10 percent or lower, or provide ports of entry with an alternative method for identifying narcotics at lower purity levels. The bill requires that any new chemical screening devices are tested to assess their limitations before acquisition. It also directs the DHS Secretary to implement a plan for developing a centralized spectral database for chemical screening devices that addresses how newly identified drug compounds will be collected, stored, and distributed to these devices in an operational environment and who the appropriate parties responsible for updates and maintenance of the database are."
H. Rept. 116-319, Part 1; House Report 116-319, Part 1
U.S. Government Publishing Office: http://www.gpo.gov/